CARLOS
SANZ GARCÍA
Postdoctoral UCM
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (5)
2023
-
Novel therapeutic avenues for the study of chronic liver disease and regeneration: The foundation of the Iberoamerican Consortium for the study of liver Cirrhosis
Gastroenterologia y Hepatologia
-
Tumor progression locus 2 (TPL2): A Cot-plicated progression from inflammation to chronic liver disease
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1869, Núm. 4
2021
-
Differential role of MLKL in alcohol-associated and non-alcohol-associated fatty liver diseases in mice and humans
JCI Insight, Vol. 6, Núm. 4
-
Fat: Quality, or quantity? what matters most for the progression of metabolic associated fatty liver disease (mafld)
Biomedicines, Vol. 9, Núm. 10
-
The Space of Disse: The Liver Hub in Health and Disease
Livers, Vol. 1, Núm. 1, pp. 3-26